Form 8-K - Current report:
SEC Accession No. 0001367644-21-000059
Filing Date
2021-04-05
Accepted
2021-04-05 07:38:33
Documents
18
Period of Report
2021-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20210404.htm   iXBRL 8-K 35732
2 EX-99 covidvaccinemanufacturin.htm EX-99 8305
8 GRAPHIC covidvaccinemanufacturin001.jpg GRAPHIC 277610
9 GRAPHIC covidvaccinemanufacturin002.jpg GRAPHIC 269494
10 GRAPHIC covidvaccinemanufacturin003.jpg GRAPHIC 33983
  Complete submission text file 0001367644-21-000059.txt   996566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20210404.xsd EX-101.SCH 2484
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20210404_cal.xml EX-101.CAL 764
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20210404_def.xml EX-101.DEF 1710
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20210404_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20210404_pre.xml EX-101.PRE 13244
11 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20210404_htm.xml XML 11300
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 21803737
SIC: 2834 Pharmaceutical Preparations